1. Home
  2. IBRX vs RIOT Comparison

IBRX vs RIOT Comparison

Compare IBRX & RIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$8.24

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

N/A

Current Price

$12.41

Market Cap

8.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
RIOT
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.1B
IPO Year
2015
2002

Fundamental Metrics

Financial Performance
Metric
IBRX
RIOT
Price
$8.24
$12.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
22
Target Price
$14.25
★ $29.38
AVG Volume (30 Days)
13.5M
★ 14.6M
Earning Date
11-10-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.71
N/A
EPS
★ N/A
N/A
Revenue
$113,288,000.00
★ $647,435,000.00
Revenue This Year
$99.98
$4.80
Revenue Next Year
$108.29
$15.71
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 668.31
71.89
52 Week Low
$1.95
$11.50
52 Week High
$12.43
$30.32

Technical Indicators

Market Signals
Indicator
IBRX
RIOT
Relative Strength Index (RSI) 43.83 31.72
Support Level $7.71 $11.68
Resistance Level $8.51 $15.40
Average True Range (ATR) 0.71 1.11
MACD -0.13 0.01
Stochastic Oscillator 18.18 14.55

Price Performance

Historical Comparison
IBRX
RIOT

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated digital infrastructure company principally engaged in developing and optimizing its large-scale power assets. The Company's business centers on enhancing its electrical infrastructure and deploying it across two complementary platforms: (i) Bitcoin Mining and (ii) scalable data center solutions designed to support non-mining workloads. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

Share on Social Networks: